Publication on NanoMosaic Technology in the, “British Journal of Anaesthesia”

NanoMosaic Nanoneedle Technology Identifies Serum Biomarker of Delirium After Cardiac Surgery BOSTON, Sept. 20, 2022 /PRNewswire/ — With NanoMosaic’s nanoneedle technology, researchers from Massachusetts General Hospital and Harvard Medical School detected Tau and phosphor-Tau proteins…

Click here to view original post